Abstract. Although now over 100 years old, the classification of climate originally formulated by Wladimir Köppen and modified by his collaborators and successors, is still in widespread use. It is widely used in teaching school and undergraduate courses on climate. It is also still in regular use by researchers across a range of disciplines as a basis for climatic regionalisation of variables and for assessing the output of global climate models. Here we have produced a new global map of climate using the Köppen-Geiger system based on a large global data set of long-term monthly precipitation and temperature station time series. Climatic variables used in the Köppen-Geiger system were calculated at each station and interpolated between stations using a two-dimensional (latitude and longitude) thin-plate spline with tension onto a 0.10.1 grid for each continent. We discuss some problems in dealing with sites that are not uniquely classified into one climate type by the Köppen-Geiger system and assess the outcomes on a continent by continent basis. Globally the most common climate type by land area is BWh (14.2%, Hot desert) followed by Aw (11.5%, Tropical savannah). The updated world Köppen-Geiger climate map is freely available electronically in the Supplementary Material Section.
To inform the United Nations Framework Convention on Climate Change (UNFCCC) fourth Biennial Assessment and Overview of Climate Finance Flows, we reviewed estimates using updated data on climate finance flows for the years 2017 and 2018, as previously reported in the Global Landscape of Climate Finance 2019.
There was great interest in the databases of standardized citation metrics across all scientists and scientific disciplines , and many scientists urged us to provide updates of the databases. Accordingly, we have provided updated analyses that use citations from Scopus with data freeze as of May 6, 2020, assessing scientists for career-long citation impact up until the end of 2019 (Table-S6-career-2019) and for citation impact during the single calendar year 2019 (Table-S7-singleyr-2019). Updated databases and code are freely available in Mendeley ( ). The original database (version 1) can also be found in , the updated (version 2) can also be found in , and any subsequent updates that might appear in the future will be generally accessible in
The updated criteria take effect on Wednesday 15 June 2022. New applicants are required to adopt these strengthened criteria immediately to join the campaign. Existing Partners and members will need to meet the new criteria by 15th June 2023 at the latest.
Through the procedures and instructions in this updated memo, OSHA will prioritize its enforcement resources to ensure employers eliminate and control workplace exposures to SARS-CoV-2, the cause of COVID-19, in non-healthcare settings. Additionally, this memorandum provides updated guidance to protect OSHA enforcement personnel.
The Centers for Disease Control and Prevention (CDC) also maintains a website that provides information for employers concerned about COVID-19 infections in the workplace. The CDC has provided specific guidance for businesses and employers at the following CDC webpage, which is updated regularly: Workplaces and Businesses.
Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) (or emtricitabine, FTC) + efavirenz (EFV) 600 mg as the preferred first- line antiretroviral therapy (ART) regimen for adults and adolescents. Since that time, scientific evidence and programmatic experience have accumulated on the use of dolutegravir (DTG) in both first- and second-line ART, including during pregnancy and tuberculosis co-treatment, and for children. In 2018, these guidelines were reviewed to provide updated guidance on preferred option for these populations which now include DTG and raltegravir (RAL), and updated recommendations on using ARV drugs for HIV post-exposure prophylaxis. Annex 3 above links to the ARV dosing guidance for children, adolescents and adults.
Changing a property during the update (up to and including the render() method) updates the changedProperties map, but doesn't trigger a new update. Changing a property after render() (for example, in the updated() method) triggers a new update cycle, and the changed property is added to a new changedProperties map to be used for the next cycle.
Sea ice data is updated daily, with a one-day lag. The orange line in extent and concentration images (left and middle) and the gray line in the time series (right) indicate 1981 to 2010 average extent for the day shown. The graph also includes lines for selected earlier years, for comparison. Learn about update delays and other problems which occasionally occur in near-real-time data. Read about the data.
As of 30 September 2021, 120 countries, representing just over half of global greenhouse gas emissions, had communicated new or updated NDCs. In addition, three G20 members have announced other new mitigation pledges for 2030.
To have any chance of limiting global warming to 1.5C, the world has eight years to take an additional 28 gigatonnes of CO2 equivalent (GtCO2e) off annual emissions, over and above what is promised in the updated NDCs and other 2030 commitments. To put this number into perspective, carbon dioxide emissions alone are expected to reach 33 gigatonnes in 2021. When all other greenhouse gases are taken into account, annual emissions are close to 60 GtCO2e. So, to have a chance of reaching the 1.5C target, we need to almost halve greenhouse gas emissions. For the 2C target, the additional need is lower: a drop in annual emissions of 13 GtCO2e by 2030.
So, while testing more often or with more tests may seem like a good idea, it can actually lead to more harms. ACS carefully evaluated the potential benefits and harms of each screening test for each age group to come up with their updated recommendations.
ASCCP (formerly known as The American Society of Colposcopy and Cervical Pathology) recently published updated guidelines for the care of patients with abnormal cervical screening test results. This was a large consensus effort involving several clinical organizations, federal agencies, and patient representatives. Several NCI scientists, including myself, performed extensive risk assessment and systematic literature reviews to support the development of the guidelines.
Today, the Biden Administration is announcing its plan to get Americans their updated COVID-19 vaccine shot this fall, to ensure that the nation continues to effectively manage COVID-19 and minimize its disruptions, and to stay prepared for whatever may come.
1. Getting Americans the best available protection through free and easy access to new, updated COVID-19 vaccines.Following actions last week by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), we are launching a new, updated COVID-19 vaccine this week. The new vaccines provide the strongest available protection from the Omicron strain of the COVID virus, which did not exist when the original vaccine was developed. As the virus continues to change, we will now be able to update our vaccines annually to target the dominant variant. Everyone age 12 years and older is eligible for these updated vaccines at least two months after their primary series or their most recent booster. Given the potential for cases to increase in the fall and winter, it is critical that Americans get a new, updated COVID-19 vaccine to stay protected. The Administration is launching a comprehensive effort to make sure that these vaccines are free, widely available, and easy to access for all Americans. 153554b96e